By Lynne Peeples
San Francisco—The full worth of cancer treatment may not be fully captured in current value models or clinical research, according to a poster presented at the 2016 annual meeting of the Academy of Managed Care Pharmacy (AMCP).
Critically missing, the researchers noted, are societal considerations and patient preferences, such as work productivity.
“A lot of studies out there may not be evaluating the true potential of these treatments,” said Khalid M. Kamal,